Page last updated: 2024-08-26

zofenopril and Hyperlipoproteinemia Type II

zofenopril has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleotti, L; Bucci, M; Casini, A; Cicala, C; Cirino, G; D'Armiento, FP; de Nigris, F; Franconi, F; Napoli, C; Roviezzo, F; Somma, P; Zuliani, P	1

Other Studies

1 other study(ies) available for zofenopril and Hyperlipoproteinemia Type II

Article	Year
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits. General pharmacology, 1999, Volume: 33, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Platelets; Captopril; Female; Hyperlipoproteinemia Type II; Immunohistochemistry; Lipoproteins, LDL; Male; Rabbits	1999

Article

Year

Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits.

General pharmacology, 1999, Volume: 33, Issue:6

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Platelets; Captopril; Female; Hyperlipoproteinemia Type II; Immunohistochemistry; Lipoproteins, LDL; Male; Rabbits

1999